• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[放射治疗在脑膜瘤治疗中的作用]

[Role of radiotherapy in the treatment of meningioma].

作者信息

Haie-Meder C, Brunel P, Cioloca C, Meder J F, Borel C, Marsiglia H, Parker F, Schlienger M

机构信息

Institut Gustave-Roussy, Villejuif, France.

出版信息

Bull Cancer Radiother. 1995;82(1):35-9.

PMID:7702938
Abstract

Between 1962 and 1986, 32 patients with intracranial meningiomas were referred to the Institut Gustave-Roussy for external radiotherapy either after incomplete surgery, or unfavorable histology (meningiosarcoma/anaplastic meningioma), or after recurrences. In the latter case, the mean time interval between the first surgery and the recurrence was 2 years (range: 1-6 years). Radiotherapy was performed using photons, electrons or mixed photons-electrons. The mean total dose was 48 Gy (range: 9-65 Gy) delivered in a mean time of 35 days with a 19 mean number of fractions. Radiotherapy was interrupted in three cases at 9 Gy-17 Gy-20 Gy because of neurological worsening. The actuarial 5-year survival was 64%. Among the 32 patients, 11 died, eight of tumoral progression or recurrence and three of other causes (one ovarian carcinoma, two unknown). Among the 21 alive patients, eight presented a recurrence; five of them could be reoperated on with two complete resections. None of the following factors were found to be of prognostic value on the survival nor on the recurrence occurrence: age, tumor location, first surgical resection type, and, in the group of patients treated at the time of recurrence, the quality of the surgery at the time of recurrence and the time interval between the first surgery and the recurrence. Only one factor was evidenced as of significant value on the recurrence as well as the 10-year survival: the total dose of irradiation with a 10-year survival rate of 74% for total doses higher than or equal to 47 Gy versus 14% when the total dose was lower than 47 Gy.

摘要

1962年至1986年间,32例颅内脑膜瘤患者因手术不彻底、组织学类型不佳(脑膜肉瘤/间变性脑膜瘤)或复发后被转诊至古斯塔夫-鲁西研究所接受外照射放疗。在后一种情况下,首次手术与复发之间的平均时间间隔为2年(范围:1 - 6年)。放疗采用光子、电子或光子 - 电子混合方式进行。平均总剂量为48 Gy(范围:9 - 65 Gy),在平均35天内给予,平均分割次数为19次。有3例患者在9 Gy - 17 Gy - 20 Gy时因神经功能恶化中断放疗。5年精算生存率为64%。在这32例患者中,11例死亡,8例死于肿瘤进展或复发,3例死于其他原因(1例卵巢癌,2例原因不明)。在21例存活患者中,8例出现复发;其中5例可再次手术,2例完全切除。未发现以下因素对生存或复发有预后价值:年龄、肿瘤位置、首次手术切除类型,以及在复发时接受治疗的患者组中,复发时手术的质量和首次手术与复发之间的时间间隔。只有一个因素被证明对复发以及10年生存率有显著价值:照射总剂量,当总剂量高于或等于47 Gy时,10年生存率为74%,而总剂量低于47 Gy时为14%。

相似文献

1
[Role of radiotherapy in the treatment of meningioma].[放射治疗在脑膜瘤治疗中的作用]
Bull Cancer Radiother. 1995;82(1):35-9.
2
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.侵袭性脑膜瘤的临床病理特征,强调放射治疗在治疗中的作用。
Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3.
3
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
4
Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.良性或非典型颅内脑膜瘤患者的分次立体定向放射治疗:长期经验及预后因素
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):809-16. doi: 10.1016/j.ijrobp.2004.07.669.
5
Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.非典型和恶性脑膜瘤:119例接受放疗患者的结局及预后因素。罕见癌症网络的多中心回顾性研究。
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1388-93. doi: 10.1016/j.ijrobp.2007.12.020. Epub 2008 Mar 4.
6
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.非典型脑膜瘤在接受全切除术后无论是否进行术后辅助放疗的长期复发率。
Neurosurgery. 2009 Jan;64(1):56-60; discussion 60. doi: 10.1227/01.NEU.0000330399.55586.63.
7
[Radiotherapy for intracranial meningioma: special reference to malignant and high risk benign meningioma].[颅内脑膜瘤的放射治疗:特别提及恶性和高危良性脑膜瘤]
Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Dec;55(15):1047-52.
8
Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.质子与光子适形放疗联合治疗颅内非典型及恶性脑膜瘤。
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):399-406. doi: 10.1016/j.ijrobp.2008.10.053. Epub 2009 Feb 7.
9
Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.适形调强质子放疗用于复发性、残留性或未经治疗的颅内脑膜瘤。
Radiother Oncol. 2004 Jun;71(3):251-8. doi: 10.1016/j.radonc.2004.02.011.
10
Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.非典型性和恶性脑膜瘤患者放疗后的长期预后——单一机构治疗的 85 例患者的临床结果,为早期放疗制定了优化指南。
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):859-64. doi: 10.1016/j.ijrobp.2011.08.010. Epub 2011 Dec 2.

引用本文的文献

1
Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases.接受手术切除的岩斜区脑膜瘤患者的临床结果及生存分析:176例病例分析
Cancer Manag Res. 2019 Jul 1;11:5949-5959. doi: 10.2147/CMAR.S200932. eCollection 2019.